First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
Kim, Sung-Bae, Meric-Bernstam, Funda, Kalyan, Aparna, Babich, Aleksei, Liu, Rong, Tanigawa, Takahiko, Sommer, Anette, Osada, Motonobu, Reetz, Frank, Laurent, Dirk, Wittemer-Rump, Sabine, Berlin, JordaLangue:
english
Journal:
Targeted Oncology
DOI:
10.1007/s11523-019-00670-4
Date:
September, 2019
Fichier:
PDF, 5.11 MB
english, 2019